[
  {
    "ts": "2025-12-29T16:27:00+00:00",
    "headline": "U.S. Embolic Protection Devices Market and Competition Analysis, 2025-2033, Featuring Abbott Laboratories, Allium Medical Solutions, Boston Scientific, Cardinal Health and More",
    "summary": "Key states, including California and Texas, lead in demand due to advanced healthcare systems and aging populations U.S. Embolic Protection Device Market U.S. Embolic Protection Device Market Dublin, Dec. 29, 2025 (GLOBE NEWSWIRE) -- The \"United States Embolic Protection Device Market Report by Product, Application, Material, End-User, States and Company Analysis, 2025-2033\" has been added to ResearchAndMarkets.com's offering.United States Embolic Protection Device Market is expected to reach US",
    "url": "https://finance.yahoo.com/news/u-embolic-protection-devices-market-162700097.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "a4a77424-96d3-3f91-92f8-c0f7169b3120",
      "content": {
        "id": "a4a77424-96d3-3f91-92f8-c0f7169b3120",
        "contentType": "STORY",
        "title": "U.S. Embolic Protection Devices Market and Competition Analysis, 2025-2033, Featuring Abbott Laboratories, Allium Medical Solutions, Boston Scientific, Cardinal Health and More",
        "description": "",
        "summary": "Key states, including California and Texas, lead in demand due to advanced healthcare systems and aging populations U.S. Embolic Protection Device Market U.S. Embolic Protection Device Market Dublin, Dec. 29, 2025 (GLOBE NEWSWIRE) -- The \"United States Embolic Protection Device Market Report by Product, Application, Material, End-User, States and Company Analysis, 2025-2033\" has been added to ResearchAndMarkets.com's offering.United States Embolic Protection Device Market is expected to reach US",
        "pubDate": "2025-12-29T16:27:00Z",
        "displayTime": "2025-12-29T16:27:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/fd5b098a4fac025a0685bbd6cc8386a0",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "U.S. Embolic Protection Device Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nSORemJtAwK78nRS.2huig--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/fd5b098a4fac025a0685bbd6cc8386a0.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XO2O7Xn6Byj6pFf2lZfc8g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/fd5b098a4fac025a0685bbd6cc8386a0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/u-embolic-protection-devices-market-162700097.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/u-embolic-protection-devices-market-162700097.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "CAH"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-29T16:42:00+00:00",
    "headline": "Reasons to Hold Veeva Systems Stock in Your Portfolio for Now",
    "summary": "VEEV's strong Q3, expanding AI strategy and major life sciences partnerships fuel growth despite rising costs.",
    "url": "https://finance.yahoo.com/news/reasons-hold-veeva-systems-stock-164200645.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "e8cda268-e763-3422-80e1-b4d5c9cb957e",
      "content": {
        "id": "e8cda268-e763-3422-80e1-b4d5c9cb957e",
        "contentType": "STORY",
        "title": "Reasons to Hold Veeva Systems Stock in Your Portfolio for Now",
        "description": "",
        "summary": "VEEV's strong Q3, expanding AI strategy and major life sciences partnerships fuel growth despite rising costs.",
        "pubDate": "2025-12-29T16:42:00Z",
        "displayTime": "2025-12-29T16:42:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZwoKmvWtG4m50IBSf0NKDQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LkiDNdOPbO2HoLFk.M.nKA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/reasons-hold-veeva-systems-stock-164200645.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/reasons-hold-veeva-systems-stock-164200645.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VEEV"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-29T15:57:00+00:00",
    "headline": "Omeros Gets FDA Approval for YARTEMLEA as First Therapy for TA-TMA",
    "summary": "OMER wins FDA approval for YARTEMLEA, the first TA-TMA therapy, marking its first commercial product and a shift to revenue generation.",
    "url": "https://finance.yahoo.com/news/omeros-gets-fda-approval-yartemlea-155700092.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "eabffa03-6a6c-3cda-8fec-6583c2be794e",
      "content": {
        "id": "eabffa03-6a6c-3cda-8fec-6583c2be794e",
        "contentType": "STORY",
        "title": "Omeros Gets FDA Approval for YARTEMLEA as First Therapy for TA-TMA",
        "description": "",
        "summary": "OMER wins FDA approval for YARTEMLEA, the first TA-TMA therapy, marking its first commercial product and a shift to revenue generation.",
        "pubDate": "2025-12-29T15:57:00Z",
        "displayTime": "2025-12-29T15:57:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/57.Lfvcoa8N_9pHFAUTShA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/39hBnd4FwGlouiqapgQKxA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/omeros-gets-fda-approval-yartemlea-155700092.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/omeros-gets-fda-approval-yartemlea-155700092.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "OMER"
            },
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]